Celltrion Healthcare, Current Stock Price Down 2.29%... Foreigners Net Buy 1,239,225 Shares in Last 5 Days

As of 2:32 PM on the 17th, Celltrion Healthcare is trading at 106,500 KRW, down 2.29% from the previous day. The trading volume is 3,322,908 shares, which is about 68.5% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.



On June 17, researcher Lee Dal-mi from SK Securities stated, "In the second half of 2020, full-scale sales of Truxima and Herzuma are expected in the U.S. market. Additionally, Inflectra, after being registered with UHC, is expected to maintain stable sales. Since both Truxima and Herzuma are anticancer drugs with high profit margins, the improvement in profitability from these two products is expected to continue in the second half of the year." Lee set the target price for Celltrion Healthcare at 140,000 KRW.



Over the past five days, individual investors have net sold 635,871 shares of Celltrion Healthcare, while foreign investors and institutions have net bought 1,239,225 shares and net sold 571,683 shares, respectively.

※Source: AI Investment Assistant AI Rassiro



※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.